| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | $5.3B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Gross Profit | $1.6B | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.4B | $0.1B | — | — | — | — | — | — |
| Operating Income | $-0.2B | $-0.1B | $0.0B | $-0.0B | $0.0B | $-0.0B | $0.0B | $0.0B |
| Net Income | $-0.3B | $0.0B | $-0.0B | $-0.0B | $0.0B | $0.0B | $0.0B | $-0.0B |
| EPS (Basic) | $-0.63 | $-0.11 | $-0.20 | $-0.03 | $0.04 | $1.51 | $0.06 | $-0.11 |
| EPS (Diluted) | $-0.63 | $-0.11 | $-0.20 | $-0.03 | $0.04 | $1.51 | $0.06 | $-0.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.9B | $5.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Assets | $5.5B | $5.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Cash & Equivalents | $2.4B | $5.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $6.2B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Liabilities | $1.6B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Stockholders' Equity | $9.7B | $5.1B | $0.0B | $0.0B | $0.0B | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.1B | $0.0B | $0.0B | — | — | $0.0B | $0.0B |
| Investing Cash Flow | $-10.6B | $-0.0B | $-0.0B | $-0.0B | — | — | $-0.0B | $-0.0B |
| Capital Expenditures | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $7.7B | $5.0B | $-0.0B | $0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |